In order for a person to be considered an eligible patient to access an investigational drug, biological product, or device pursuant to this chapter, a physician must document in writing that the person: (1) Has a terminal illness; (2) Has, in consultation with the physician, considered all other treatment options currently approved by the federal Food and Drug Administration; (3) Has been given a recommendation by the physician for an investigational drug, biological product, or device; and (4) Has given written informed consent for the use of the investigational drug, biological product, or device. Added by 2016 Ga. Laws 422,§ 1, eff. 7/1/2016. In order for a person to be considered an eligible patient to access an investigational drug, biological product, or device pursuant to this chapter, a physician must document in writing that the person: (1) Has a terminal illness; (2) Has, in consultation with the physician, considered all other treatment options currently approved by the federal Food and Drug Administration; (3) Has been given a recommendation by the physician for an investigational drug, biological product, or device; and (4) Has given written informed consent for the use of the investigational drug, biological product, or device. Added by 2016 Ga. Laws 422,§ 1, eff. 7/1/2016. In order for a person to be considered an eligible patient to access an investigational drug, biological product, or device pursuant to this chapter, a physician must document in writing that the person: (1) Has a terminal illness; (2) Has, in consultation with the physician, considered all other treatment options currently approved by the federal Food and Drug Administration; (3) Has been given a recommendation by the physician for an investigational drug, biological product, or device; and (4) Has given written informed consent for the use of the investigational drug, biological product, or device. Added by 2016 Ga. Laws 422,§ 1, eff. 7/1/2016. In order for a person to be considered an eligible patient to access an investigational drug, biological product, or device pursuant to this chapter, a physician must document in writing that the person: (1) Has a terminal illness; (2) Has, in consultation with the physician, considered all other treatment options currently approved by the federal Food and Drug Administration; (3) Has been given a recommendation by the physician for an investigational drug, biological product, or device; and (4) Has given written informed consent for the use of the investigational drug, biological product, or device.
‹ Prev All Georgia sections Next ›
Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.